0001788542-22-000002.txt : 20220311
0001788542-22-000002.hdr.sgml : 20220311
20220311161025
ACCESSION NUMBER: 0001788542-22-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220309
FILED AS OF DATE: 20220311
DATE AS OF CHANGE: 20220311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mottiwala Aziz
CENTRAL INDEX KEY: 0001788542
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 22733237
MAIL ADDRESS:
STREET 1: 233 WILSHIRE BOULEVARD
STREET 2: SUITE 280
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wf-form4_164703293653715.xml
FORM 4
X0306
4
2022-03-09
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001788542
Mottiwala Aziz
C/O TARSUS PHARMACEUTICALS, INC.
15440 LAGUNA CANYON ROAD, SUITE 160
IRVINE
CA
92618
0
1
0
0
Chief Commercial Officer
Stock Option (right to buy)
19.59
2022-03-09
4
A
0
65312
0
A
2032-03-08
Common Stock
65312.0
65312
D
Restricted Stock Units
2022-03-09
4
A
0
19160
0
A
Common Stock
19160.0
19160
D
25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service.
/s/ Leonard M. Greenstein, Attorney-in-Fact
2022-03-11